Stereotactic biopsy in gliomas guided by 3-tesla 1H-chemical- shift imaging of choline

Stereotactic and Functional Neurosurgery

Volumn 86, Issue 5, 2008, Pages 300-307

  Hermann, Elvis J ^a,b   Hattingen, Elke ^a   Krauss, Joachim K ^b   Marquardt, Gerhard ^a   Pilatus, Ulrich ^a   Franz, Kea ^a   Setzer, Matthias ^a   Gasser, Thomas ^a   Tews, Dominique S ^a   Zanella, Friedhelm E ^a   Seifert, Volker ^a   Lanfermann, Heinrich ^a  

^a GOETHE UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Chemical shift imaging; Choline; Low grade glioma; Stereotactic biopsy

Indexed keywords

CHOLINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; MALE; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOTACTIC BIOPSY; THREE DIMENSIONAL IMAGING; WORLD HEALTH ORGANIZATION;

ADULT; AGED; ASTROCYTOMA; BIOPSY; BRAIN; BRAIN NEOPLASMS; CHOLINE; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PROTONS; SEVERITY OF ILLNESS INDEX; STEREOTAXIC TECHNIQUES; YOUNG ADULT;

EID: 51349099766     PISSN: 10116125     EISSN: None     Source Type: Journal    
DOI: 10.1159/000155232     Document Type: Article

References (45)

1. Shetter AG, Bertuccini TV, Pittman HW: Closed needle biopsy in the diagnosis of intracranial mass lesions. Surg Neurol 1977;8:341-345.
2. Boethius J, Collins VP, Edner G, Lewander R, Zajicek J: Stereotactic biopsies and computer tomography in gliomas. Acta Neurochir (Wien) 1978;40:223-232.
3. Chamberlain MC, Murovic JA, Levin VA: Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas. Neurology 1988;38:1371-1374.
4. Muacevic A, Kreth FW: Significance of stereotactic biopsy for the management of WHO grade II supratentorial glioma (in German). Nervenarzt 2003;74:350-354.
5. White ML, Zhang Y, Kirby P, Ryken TC: Can tumor contrast enhancement be used as a criterion for differentiating tumor grades of oligodendrogliomas? AJNR Am J Neuroradiol 2005;26:784-790.
6. Alavi J, Alavi A, Chawluk J, Kushner M, Powe J, Hickey W, Reivich M: Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer 1988;62:1074-1078.
7. 18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. Invest Radiol 1986;22:360-371.
8. Levivier M, Goldman S, Bidaut LM, Luxen A, Stanus E, Przedborski S, Balériaux D, Hildebrand J, Brotchi J: Positron emission tomography-guided stereotactic brain biopsy. Neurosurgery 1992;31:792-797.
9. 18F] fluorodeoxyglucose. J Neurosurg 1995;82:445-452.
10. 11C] methionine in 45 PET-guided stereotactic brain biopsies. J Neurosurg 2004;101:476-483.
11. Wong TZ, van der Westhuizen GJ, Coleman RE: Positron emission tomography imaging of brain tumors. Neuroimaging Clin N Am 2002;12:615-626.
12. Pirotte B, Acerbi F, Lubansu A, Goldman S, Brotchi J, Levivier M: PET imaging in the surgical management of pediatric brain tumors. Childs Nerv Syst 2007;23:739-751.
13. Goldman S, Levivier M, Pirotte B, Brucher JM, Wikler D, Damhaut P, Stanus E, Brotchi J, Hildebrand J: Regional glucose metabolism and histopathology of gliomas. Cancer 1996;78:1098-1106.
14. Pirotte B, Lubansu A, Massager N, Wikler D, Goldman S, Levivier M: Results of positron emission tomography guidance and reassessment of the utility of and indications for stereotactic biopsy in children with infiltrative brainstem tumors. J Neurosurg 2007;107:392-399.
15. 11C-methionine for PET-guided stereotactic brain biopsy of gliomas. J Nucl Med 2004;45:1293-1298.
16. Goldman S, Levivier M, Pirotte B, Brucher JM, Wikler D, Damhaut P, Dethy S, Brotchi J, Hildebrand J: Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy. J Nucl Med 1997;38:1459-1462.
17. 18F] fluoro-2-deoxy-D-glucose in the low-grade glioma. Neurosurgery 1996;39:470-476.
18. Poptani H, Gupta RK, Roy R, Pandey R, Jain VK, Chhabra DK: Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. AJNR Am J Neuroradiol 1995;16:1593-1603.
19. Lee J, Yamaguchi T, Abe A, Shizukuishi K, Uemura H, Miyagi E, Sakata K, Inoue T: Clinical evaluation of choline measurement by proton MR spectroscopy in patients with malignant tumors. Radiat Med 2004;22:148-154.
20. Shimizu H, Kumabe T, Shirane R, Yoshimoto T: Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. AJNR Am J Neuroradiol 2000;21:659-665.
21. Herminghaus S, Pilatus U, Moller-Hartmann W, Raab P, Lanfermann H, Schlote W, Zanella FE: Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors. NMR Biomed 2002;15:385-392.
22. Tedeschi G, Lundbom N, Raman R, Bonavita S, Duyn JH, Alger JR, Di Chiro G: Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 1997;87:516-524.
23. Chen J, Huang SL, Li T, Chen XL: In vivo research in astrocytoma cell proliferation with 1 H-magnetic resonance spectroscopy: correlation with histopathology and immunohistochemistry. Neuroradiology 2006;48:312-318.
24. Stadlbauer A, Gruber S, Nimsky C, Fahlbusch R, Hammen T, Buslei R, Tomandl B, Moser E, Ganslandt O: Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. Radiology 2006;238:958-969.
25. Chen CY, Lirng JF, Chan WP, Fang CL: Proton magnetic resonance spectroscopy-guided biopsy for cerebral glial tumors. J Formos Med Assoc 2004;103:448-458.
26. Croteau D, Scarpace L, Hearshen D, Gutierrez J, Fisher JL, Rock JP, Mikkelsen T: Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analysis of patients with untreated glioma. Neurosurgery 2001;49:823-829.
27. Hall WA, Martin A, Liu H, Truwit CL: Improving diagnostic yield in brain biopsy: coupling spectroscopic targeting with realtime needle placement. J Magn Reson Imaging 2001;13:12-15.
28. Liu H, Hall WA, Martin AJ, Truwit CL: An efficient chemical shift imaging scheme for magnetic resonance-guided neurosurgery. J Magn Reson Imaging 2001;14:1-7.
29. 1H CSI)-directed stereotactic biopsy. Acta Neurochir (Wien) 2001;143:45-49.
30. 11C-Methionine positron emission tomography for preoperative evaluation of suggestive low-grade gliomas. Zentralbl Neurochir 2007;68:19-23.
31. Dowling C, Bollen AW, Noworolski SM, McDermott MW, Barbaro NM, Day MR, Henry RG, Chang SM, Dillon WP, Nelson SJ, Vigneron DB: Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol 2001;22:604-612.
32. Lange T, Dydak U, Roberts TP, Rowley HA, Bjeljac M, Boesiger P: Pitfalls in lactate measurements at 3 T. AJNR Am J Neuroradiol 2006;27:895-901.
33. Li X, Vigneron DB, Cha S, Graves EE, Crawford F, Chang SM, Nelson SJ: Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo. AJNR Am J Neuroradiol 2005;26:760-769.
34. Ng WH, Lim T: Targeting regions with highest lipid content on MR spectroscopy may improve diagnostic yield in stereotactic biopsy. J Clin Neurosci 2008;15:502-506..
35. Li X, Jin H, Lu Y, Oh J, Chang S, Nelson SJ: Identification of MRI and 1 H MRSI parameters that may predict survival for patients with malignant gliomas. NMR Biomed 2004;17:10-20.
36. Li X, Lu Y, Pirzkall A, McKnight T, Nelson SJ: Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients. J Magn Reson Imaging 2002;16:229-237.
37. Tzika AA, Zurakowski D, Poussaint TY, Goumnerova L, Astrakas LG, Barnes PD, Anthony DC, Billett AL, Tarbell NJ, Scott RM, Black PM: Proton magnetic spectroscopic imaging of the child's brain: the response of tumors to treatment. Neuroradiology 2001;43:169-177.
38. Michaelis T, Merboldt KD, Bruhn H, Hanicke W, Frahm J: Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 1993;187:219-227.
39. 31P NMR analyses of phosphocholine metabolism in rat glioma cells. Magn Reson Med 1994;32:310-318.
40. Ackerstaff E, Glunde K, Bhujwalla ZM: Choline phospholipid metabolism: a target in cancer cells? J Cell Biochem 2003;90:525-533.
41. Gupta RK, Cloughesy TF, Sinha U, Garakian J, Lazareff J, Rubino G, Rubino L, Becker DP, Vinters HV, Alger JR: Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol 2000;50:215-226.
42. 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci 1996;58:1929-1935.
43. 1H magnetic resonance spectroscopy for the characterization of primary brain tumors: report of two cases. Stereotact Funct Neurosurg 2005;83:122-127.
44. Reijneveld JC, van der Grond J, Ramos LM, Bromberg JE, Taphoorn MJ: Proton MRS imaging in the follow-up of patients with suspected low-grade gliomas. Neuroradiology 2005;47:887-891.
45. Mittler MA, Walters BC, Stopa EG: Observer reliability in histological grading of astrocytoma stereotactic biopsies. J Neurosurg 1996;85:1091-1094.